Cargando…

SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?

Detalles Bibliográficos
Autor principal:	Maisch, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175831/ https://www.ncbi.nlm.nih.gov/pubmed/32322935 http://dx.doi.org/10.1007/s00059-020-04925-z

Ejemplares similares

SARS-CoV-2, vaccination or autoimmunity as causes of cardiac inflammation. Which form prevails?
por: Maisch, Bernhard
Publicado: (2023)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Hyperinflammation bei SARS-CoV-2-Infektion
Publicado: (2020)

A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19
por: Cothran, Thomas P., et al.
Publicado: (2020)

PQQ Supplementation and SARS-CoV-2 Spike Protein-Induced Heart Inflammation
por: Boretti, Alberto
Publicado: (2022)

Effect of polymerised type I collagen on hyperinflammation of adult outpatients with symptomatic COVID‐19
por: Méndez‐Flores, Silvia, et al.
Publicado: (2022)

Not the Virus but Treatment and Immune Response Cause SARS-CoV-2-associated Neuropathy
por: Finsterer, Josef
Publicado: (2022)

Heart rate at presentation of COVID-19: Can SARS-CoV-2 be a cause of dysautonomia?
por: Severo Sánchez, Andrea, et al.
Publicado: (2022)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure
por: Masotti, Luca, et al.
Publicado: (2022)

Olfactory and gustatory dysfunction caused by SARS-CoV-2: Comparison with cases of infection with influenza and other viruses
por: Nakashima, Tsutomu, et al.
Publicado: (2020)

Does SARS-CoV-2 truly cause infectious myopathy?
por: Finsterer, Josef, et al.
Publicado: (2021)

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
por: Gulmez, Ali Osman, et al.
Publicado: (2023)

Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation
por: Lu, Shuaiyao, et al.
Publicado: (2020)

Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice
por: Gao, Wen-Cong, et al.
Publicado: (2021)

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China
por: Akhmetzhanov, Andrei R.
Publicado: (2020)

Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis
por: Lucijanic, Marko, et al.
Publicado: (2022)

Intrauterine Transmission of SARS-CoV-2 (COVID-19 Virus)
por: agarwal, Mukta, et al.
Publicado: (2021)

Outcome of patients receiving V-V ECMO for SARS-CoV-2 severe acute respiratory failure
por: Morris, I.S., et al.
Publicado: (2023)

SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade
por: Farina, Andrea, et al.
Publicado: (2020)

Deficiency of HTR4 and ADRB1 caused by SARS-CoV-2 spike may partially explain multiple COVID-19 related syndromes including depression, cognitive impairment, loss of appetite, heart failure, and hypertension
por: Lv, Lu, et al.
Publicado: (2022)

Is a COPD patient protected against SARS-CoV-2 virus?
por: Daubin, C., et al.
Publicado: (2021)

Encephalitis associated with the SARS-CoV-2 virus: A case report
por: Vandervorst, Fenne, et al.
Publicado: (2020)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Does SARS-CoV-2 re-infection depend on virus variant?
por: Gautret, Philippe, et al.
Publicado: (2021)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022)

Caring for cardiac patients amidst the SARS-CoV-2 pandemic: The scrambled pieces of the puzzle
por: Félix-Oliveira, Afonso, et al.
Publicado: (2020)

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
por: Pan, Pan, et al.
Publicado: (2021)

A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
por: Brandenburg, Klaus, et al.
Publicado: (2023)

Case report: Fatal lung hyperinflammation in a preterm newborn with SARS-CoV-2 infection
por: Aguilar-Caballero, Daniela, et al.
Publicado: (2023)

Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient
por: Pla, Jordi Juanola, et al.
Publicado: (2020)

Testicles, adipose organ and heart: A new axis in the management of SARS-CoV-2?
por: Bertuccioli, Alexander, et al.
Publicado: (2021)

Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient
por: Pla, Jordi Juanola, et al.
Publicado: (2020)

The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland
por: Bell, Samira, et al.
Publicado: (2022)

Consider multisystem inflammatory syndrome in children with kidney failure after SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2022)

Collateral damage: Fear from SARS-CoV2-infection causing Takotsubo cardiomyopathy
por: Uhe, Tobias, et al.
Publicado: (2020)

Response to letter to the editor “Does SARS-CoV-2 truly cause infectious myopathy?”
por: Chang, Kai Chieh
Publicado: (2021)

Alert for SARS-CoV-2 infection caused by fecal aerosols in rural areas in China
por: Meng, Xiujuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_081jialqh1rckgleih0to1na75